Treatment of patients with functional neurological symptoms: a randomized controlled trial

• Conditions: Medically unexplained symptoms; unexplained physical symptoms; 10077546

• Registration Number: NL-OMON32277
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

Patients (>18 years old) with neurological physical symptoms unexplained by disease. The following clusters of symptoms will be included:
* Tension type headache
* Back and neck pain
* Pseudo movement disorders
* Mainly sensory disturbances
* Mainly motor disturbances
* Pseudo-epilepsy

Exclusion Criteria

* Duration of symptoms more than one year
* Patients known prior to assessment to have psychiatric disorders other than somatoform, depressive, or anxiety disorders
* Patients with a primary diagnosis of a severe mood, anxiety, or psychotic disorders requiring psychiatric treatment
* Patients who are in dispute about financial or social benefit
* Patients suffering from a major somatic disease, incl neurological disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome is the patient*s level of activities of daily living 12<br /><br>months after Randomisation. Physical disability will be assessed with the AMC<br /><br>linear disability scale (ALDS). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes are the 'hospital anxiety and depression scale' (HADS),<br /><br>symptom score, work/leisure activities, absence of work, medical consumption<br /><br>and quality of life (SF-36).</p><br>